Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance (ITN022ST).
Phase of Trial: Phase I/II
Latest Information Update: 30 Jul 2013
At a glance
- Drugs Alemtuzumab (Primary) ; Mycophenolate mofetil; Sirolimus; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 30 Jul 2013 Results published in Transplantation.
- 01 Jun 2011 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.